Navel G Daver

248PUBLICATIONS
560CO-AUTHORS
Medical molecular engineering of nucleic acids and proteinsRegenerative medicine (incl. stem cells)Haematological tumoursGene and molecular therapyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (248)

|Aug 13, 2026
Clinical outcomes associated with NPM1 mutations in newly diagnosed acute myeloid leukemia.

|Jul 13, 2026
Magrolimab Plus Azacitidine Versus Placebo Plus Azacitidine in Patients With Untreated Higher-Risk Myelodysplastic Syndromes: The Phase III ENHANCE Study.

|Jul 07, 2026
Tagraxofusp, Azacitidine, and Venetoclax in Blastic Plasmacytoid Dendritic Cell Neoplasm.

|Jul 02, 2026
Risk Prognostication After Hypomethylating Agents Combined With Venetoclax in AML: The PRISM Risk Model.

|Jun 22, 2026
Investigational Clinical Trial Agents versus Conventional Second Salvage Therapies in Patients with Relapsed/Refractory Acute Myeloid Leukemia.

|Jun 15, 2026
Prognostic and therapeutic implications of BRAF mutations in acute myeloid leukemia.

Pageof 42

Frequent Collaborators

164 joint publications

Courtney DiNardo

148 joint publications

Tapan M Kadia

123 joint publications

Hagop M Kantarjian

110 joint publications

Nicholas Short